From a universal flu vaccine that could save us from a pandemic, to vaccines that target ticks and mosquitoes, Horizon looks at the science of vaccines during the month of February.
The bacteria that causes TB infects over a quarter of the world’s population, and we speak to the European scientists who are closing in on a vaccine for the disease that could save millions of lives.
We also look at the rise of measles and mumps as a result of fears over the MMR vaccination – and interview researchers who are collecting information to try to prevent unnecessary future vaccine scares.
The days when measles was a killer disease affecting thousands are firmly in the past thanks to mass immunisations. However, a fall in vaccination rates means the disease is starting to make an unwelcome comeback in Europe – and European scientists have found a way to help.
The fight against poverty-related diseases is gaining ground as scientists prepare trials of vaccines for hookworm, leishmaniasis and other parasitic diseases common in the developing world, thanks to the support of public research funding.
Imagine being able to hear, feel and think – but not see or move. Around you, you can hear doctors and family members saying that you cannot understand or make decisions.
Concentrated solar power (CSP) could have the potential to energise remote areas of the world, but it faces one major obstacle – the amount of water it uses. Now, thrifty water sprinklers, tailor-made rotors and hybrid sunlight-biomass boilers could cut the water bill of concentrated solar power and even help generate electricity when the sun doesn't shine.
You’ve heard of Google, but you probably haven’t heard of Qwant…. yet. This French search engine, based around the concept of privacy, is just one of a number of companies to receive growth finance from the EU to promote innovation and help European companies compete with their American rivals.
It could help them communicate.
It could help bring affordable electricity to arid regions.
Consumers can now design their own trainers.